Anti-Mi-2 autoantibody is strongly associated with dermatomyositis and found in sera of 20% of patients. Mi-2 antigen contains at least eight components and previous evidence suggested that the 240-kD protein was the antigenic component for at least some sera. In this study, anti-Mi-2 patient sera were used to screen human thymocyte and HeLa cell Xgtll expression libraries, and two clones from each had plaques specifically reactive with anti-Mi-2 sera.
Introduction
The idiopathic inflammatory myopathies polymyositis and dermatomyositis (DM)' are associated with serum autoantibodies 1 . Abbreviations used in this paper: aa, amino acids; DM, dermatomyositis; IPP, immunoprecipitation; IPPs, immunoprecipitates; tRNA, transfer RNA.
to intracellular proteins in 60-80% of patients (1) . Certain of these autoantibodies are found exclusively or predominantly in myositis patients, referred to as myositis-specific autoantibodies. The disease specificity of these autoantibodies makes them of special interest, since it suggests a fundamental relationship to etiologic and pathogenetic factors in the disease (2) . The most common of these overall is anti-Jo-i (3), which reacts with histidyl-tRNA (transfer RNA) synthetase (4) . Several other myositis-specific autoantibodies are directed at other aminoacyl-tRNA synthetases (5) (6) (7) or other cytoplasmic antigens such as the signal recognition particle (8) .
One myositis-specific autoantibody, however, anti-Mi-2, reacts with a nuclear antigen that is absent from the cytoplasm and the nucleoli (9) . Anti-Mi-2 is also unique in that it is almost exclusively associated with DM rather than polymyositis (PM) (9, 10) , and has been found in 15-20% of DM patients (9) . This is the only autoantibody for which such a close association with DM has been established. Patients with anti-Mi-2 often have florid cutaneous manifestations including typical Gottron's papules and heliotrope lesions, and involvement of the base of the neck and upper back ("V" and "shawl" patterns) (10) . Anti-Mi-2 is found in all classes of DM patients including children (9, 11, 12 ), but is not associated with the constellation of findings seen with antisynthetases (10), such as interstitial lung disease, arthritis, or Raynaud's phenomenon.
Despite these interesting features of the autoantibody, little is known about the antigen to which it is directed. By immunoprecipitation (IPP) from [35S] methionine-labeled HeLa cells, all anti-Mi-2 sera show a series of at least eight polypeptides that include a prominent band of 240 kD, along with weaker bands of 200, 150, 75, 65, 63, 50, and 34 kD ( 11) , raising the possibility of a macromolecular complex. The relative prominence of 240-kD protein suggests that it is directly reactive, but reaction of anti-Mi-2 autoantibodies by immunoblot has been difficult to demonstrate. Recently, however, about half of antiMi-2 sera were shown to react by blot with the HeLa Mi-2 240-kD protein, and a smaller proportion with other Mi-2 proteins, by using an Mi-2-enriched antigen prepared by IPP ( 13) . It was not known whether the other sera also recognize the 240-kD protein under other conditions. No nucleic acid has been associated with Mi-2 antigen, and there is no information regarding its function.
In this study, the 240-kD protein was confirmed to be the major Mi-2 antigenic protein, and a major immunoreactive region was identified and characterized by isolation and characterization of cDNA clones encoding a portion of the protein.
ferred from other centers as part of other studies. 44 sera were identified as anti-Mi-2 positive by double immunodiffusion with a standard serum identical with the original prototype (9) , and confirmed using IPP from [355]methionine-labeled HeLa cells (13) . 42 of 44 were from DM patients (1 amyopathic), and 2 from PM patients. In a previous study ( 13) , 22 of the anti-Mi-2 sera used here were determined to be reactive by immunoblot against HeLa 240-kD protein, and 22 were negative. Control sera included 22 sera from normal laboratory workers, and 22 sera (19 from myositis patients) with other autoantibodies, including anti-Jo-i, anti-PL-7, anti-PL-12, anti-OJ, anti-PM-Scl, anti-Ro, anti-La, anti-RNP, and anti-Sm.
Isolation of clones. Two Xgtl1 cDNA libraries, one derived from human thymocytes and the other from HeLa cells (Clontech, Palo Alto, CA), were independently screened with anti-Mi-2 patient plasma from patient ML, from the method of Young and Davis (14) . Sera were either used directly at 1:500 dilution in Tris-buffered saline with 0.05% Tween 20, or were used at 1:100 dilution after preincubation with Escherichia coli proteins and plaques of wild-type Xgtl 1 phage on nitrocellulose filters to remove antibodies to E. coli proteins. 5% nonfat milk in serum dilution buffer was used as blocking agent. Goat anti-human IgG/alkaline phosphatase (Sigma Chemical Co., St. Louis MO), was used as conjugate, and bromo-chloro-indolyl phosphate/nitroblue tetrazolium as substrate. Reactive clones were plaque purified and further tested as below.
Clone L4 cDNA was labeled with 32P and used as a probe to screen a human thymocyte "5' stretch" Xgtl 1 cDNA library (Clontech). After hybridization with transferred plaques, filters were developed by autoradiography, and positive clones were plaque purified. Those with the longest cDNA inserts were selected and further characterized.
Testing of clones. Further serologic testing of clone L4 was performed using a plaque-test in which E. coli Y1090 was incubated with a 1:1 mixture of purified reactive phage and wild-type phage, so that anti-Mi-2 sera would react with 50% of plaques, with 50% as negative controls ( 15 ) . Portions of nitrocellulose were incubated separately with each test serum and developed as described above for screening. Affinity purification of antibodies reactive with plaque proteins of LI or L4 recombinant Xgtll was accomplished as previously described (15 (16, 22) .
Expression of C4 cDNA fragments. The cDNA of clone C4 was amplified by PCR using gene-specific oligonucleotide primers (5'-TCCAGCAGAAGCAAAAGCAAGTG-3' and 5 '-TfATCCACACTG-TGGTTGATG-3'), with BamHI and HindII sites added to facilitate subcloning into pQE expression vector. This PCR product was digested with BamHI and HindHII to yield a 0.5-kb 5' fragment (C4a; Fig. 1 ) and 1.1-kb 3' portion (C4b). Two fragments that covered the 1.1-kb 3' portion (C4b) were separately prepared by PCR with gene-specific primers with BamHI or HindUI sites attached, including a 0.6-kb central C4 fragment (C4c; Fig. 1 ) (5 '-TGATGGACGCAAGAAGC-3' and 5'-TTAGACAATGAATGTGG-3') and a 0.5-kb 3' fragment (C4d; Fig.  1 ) (5 '-ACATTCATTGTCTAAAC-3' and 5 '-ATCCACACTGTGGTT-GATG-3'). The individual isolated DNA fragments were digested with BamHI and/or HindII, subcloned into pQE plasmid, and transformed into E. coli M15/pREP4 using the Qiaexpressionist system (Qiagen Inc., Chatsworth, CA). The protein product was solubilized in guanidine/HCl and purified using Ni-NTA affinity chromatography with a urea gradient according to manufacturer's instructions. Urea was reduced to a concentration of 0.1 M by dialysis.
Attempts to produce a Xgtl 1 lysogen in Y1089 were performed as described previously (15) . Expression of the intact C4 cDNA was attempted as described above using the Qiaexpressionist system, as well as the ThioFusion Expression System and Baculovirus Protein Expression System (Invitrogen) according to manufacturer's instructions.
Production of rabbit antiserum. A New Zealand white male rabbit was immunized with 500 jig of the purified 20-kD expressed product ("NH2-terminal protein") of the 5' fragment of Mi-2 clone C4 (C4a; Fig. 1 
Results
Identification of cDNA clones. From initial screening of 1,000,000 plaques, two clones were identified from the HeLa library (L1-L2) and two from the thymocyte library (L3-L4) that reacted strongly with 6 anti-Mi-2 sera. Clones LI and L2 each reacted weakly with only one of eight control sera, and clones L3 and L4 were negative with all eight. Clone L4 was further tested for reaction with anti-Mi-2 sera from a total of 44 different patients (Fig. 2 ), including 22 that had reacted by blot with the 240-kD protein, and 22 that had not ( 13) , 44 antiMi-2 negative control sera were also tested, including 22 from normals and 22 from patients with myositis or with other autoantibodies. All 44 anti-Mi-2 sera were positive, and all 44 control sera were negative (Fig. 2) .
Affinity-purified antibodies from plaques of clone L4 strongly reacted with plaques of each of the four clones, and showed similar reaction to that of whole anti-Mi-2 serum by indirect immunofluorescence on HEp-2 cells. Eluates from wild-type plaques were negative in both assays. By kD protein seen with whole anti-Mi-2, and faintly the 65-and 63-kD proteins (Fig. 3) . Affinity-purified antibodies also reacted by immunoblot with the 240-kD protein but not other Mi-2 proteins when tested against anti-Mi-2 IPPs (Fig. 4) (Fig. 5 A) , showing that the cDNA contained 1054 bp encoding 351 amino acids (aa) without a stop codon, a probable initiation site (24), or a poly-A tail, indicating that it was a portion of a larger cDNA. This was verified by Northern blot of labeled L4 cDNA against total HeLa cell RNA, which revealed a single band of -7.5-8.0 kb (Fig. 6) .
12 cDNA clones identified by probing a Xgtll thymocyte library with labeled L4 cDNA were then studied, and all 12 had inserts between 0.5 and 1.6 kb. Sequencing of both strands of the longest cDNA, clone C4, showed 1,589 bp (excluding 5' and 3' EcoRI-linkers), including the above L4 sequence and extending 525 bp beyond its 5' end and 29 bp beyond its 3' end ( Fig. 5 A) . C4 cDNA extended the L4 cDNA open reading frame, still without stop codon or probable start site, encoding 529 aa with predicted molecular mass of 59.3 kD.
Expression of cDNA fragments. An attempt was made to produce the L4 fusion protein by using a lysogen of L4 phage in E. coli Y1089, but surprisingly, > 99% of infected E. coli died, with surviving colonies showing altered morphology with ragged and pointed edges. Similarly, failure of attempted expression of C4, L4, or C4c cDNAs in several systems, with resulting deletions or other instability of the plasmid vector, indicated that the cDNA products were toxic to E. coli.
Successful expression of the 5' and 3' portions (C4a and C4d), but not the central portion, of the C4 cDNA was achieved, however. Anti-Mi-2 serum from patient VA, which had reacted strongly with the 240-kD Mi-2 protein by immunoblot of IPPs, reacted strongly with the 20-kD NH2-terminal protein (Fig. 7) , which was not present in the fusion proteins of LI-L4 -gtl 1 clones, although 11 (Fig. 4, Inh) , but, as expected, not with a control recombinant protein (PM-Scl 100 kD, [15] ), providing further confirmation that the C4 NH2-terminal protein represented a portion of Mi-2 240 kD. Unlike patient sera, the rabbit antiserum showed very little activity by EPP, either being negative or, in some experiments, weakly positive for 240 kD, always negative for 150 kD, and equivocal for other Mi-2 components. This suggested that the portion of 240 kD protein corresponding to the C4 NH2-terminal region may not be exposed in the native conformation. The rabbit serum was also negative by immunodiffusion against calf thymus extract. However, indirect immunofluorescence with rabbit antiserum showed strong nuclear staining, in a pattern similar to that of anti-Mi-2 sera, except for nonspecific cytoplasmic staining present also with preimmune serum.
Testing recombinant protein. After in vitro transcription and translation of the full C4 cDNA in a rabbit reticulocyte system, the postimmune rabbit serum and anti-Mi-2 patient serum VA reacted with a 60-kD protein that was identical in size to the 35S-labeled translation product, of expected size for the C4 product, and present only in lysates translating the C4 clone, rather than control cDNA (Fig. 8) . The other four anti-Mi-2 sera shown in Fig. 8 , two of which were Mi-2 240 kD blot positive, did not react with the translation product by immunoblot. Control sera were also negative. Five additional anti-Mi-2 sera (two of which were 240 kD blot positive) were similarly tested in a separate experiment (not shown), and all were negative, while serum VA and postimmune rabbit serum were again positive.
Amino acid sequence analysis. The translated protein sequence of the C4 clone is indicated in Fig. 5 A, in proline residues, one 11 of 22 (50%), the other 15 of 57 (26%); (b) one region rich in alanine residues, 14 of 16 (88%); (c) two regions rich in basic amino acids, one 22 of 50 (44% Arg+Lys), the other 11 of 16 (69% Arg+Lys;); (d) two regions rich in acidic residues, 8 of 14 (57% Asp+Glu) and 17 of 21 (81% Asp+Glu), (e) three regions with a composition consistent with PEST/D regions; and (f) four regions with a potential zinc-finger structure, arranged as two sets of two regions (Fig. 5 A) . The two potential zinc fingers of each set were separated by four aa, and the sets were separated by a region that included the 21 aa acidic region, rich in glutamic acid. The two sets had 55% similarity to each other in sequence and spacing, as determined by dot plot analysis. The first potential finger of each set began and ended with two cystines separated by two aa (C-X-X-C) with an eight aa loop between, while the second potential finger of each set began with histidine and cystine separated by two aa (H-X-X-C), and ended with C-X-X-C, with a 14 aa loop.
The nucleotide and amino acid sequence of C4 cDNA were unique in the GenBank, EMBL and PIR databases. pressed sequence tag from a cDNA derived from human brain (EST03869, accession T05980, clone HFBDK47) (25) had 88% identity with Mi-2 in the Zn-finger region, and 44% identity and 94% similarity (with gaps for alignment) in the adjacent NH2-terminal region. Two other proteins, human hrx and laminin a chain precursor, had significant identity (42 and 30%) and similarity (79 and 57%) that was limited to the Zn-finger regions.
Discussion
We have isolated a cDNA clone encoding a portion of the Mi-2 240-kD protein that was recognized by all tested patients with anti-Mi-2 autoantibodies. Three independent lines of evidence were used to establish the identity of the protein partially encoded by this cDNA as Mi-2 antigen. The first was serological testing, which demonstrated complete concordance of the presence or absence of anti-Mi-2 with reaction with the recombinant plaques. We have now tested anti-Mi-2 sera from over 60 patients, and there is still a 100% correlation. Second, affinitypurified antibodies from plaques of clone L4, but not wild-type, Figure 7 . Immunoblot of recombinant NH2-terminal protein. which will require further study. The affinity-purified antibodies studied here did not react with other Mi-2 components.
Epitopes. It is noteworthy that sera from all 44 patients reacted with the portion of the 240-kD protein encoded by the L4 cDNA, representing < 20% of the molecule. Furthermore, reaction with this portion was dependent on more than just the linear sequence for at least some of the sera, since they did not blot the in vitro-produced protein, even when they blotted the whole natural protein. This suggests that the immunoblot activity against the whole protein usually represents reaction with other portions of the protein not included in L4, and that the epitope(s) recognized by most sera in the plaque test were conformational, and either disrupted by the immunoblot procedure or not formed in vitro. These findings suggest a similarity in the response of different anti-Mi-2 patients, although serum VA showed significant additional reactivity.
The possibility of a predominant or universally shared epitope is consistent with a molecular mimicry hypothesis, although other concepts could also explain this. The factors which lead to production of autoantibodies to this protein in some DM patients, and not in other diseases, remain unclear.
Analysis of sequence. The cDNA of clone C4 is a portion of a larger cDNA, which appears to be 7.5 kb. It represents only 20% of the full length Mi-2 transcript, and 25% of a 240-kD protein, the average estimated relative size of the HeLa protein over a series of experiments. 7.5 kb is adequate to encode a 240-kD protein.
It was of interest that all four initial cDNA L clones were truncated within the coding region at identical points on both ends, despite coming from two different libraries. This suggests a specific reason for susceptibility of mRNA or cDNA to degradation at these points, or secondary structure resistant to denaturation. Attempted extension of the 3' cDNA end by anchored PCR, using oligo dT and gene-specific primers (15) , was unsuccessful.
Analysis of the predicted amino acid sequence encoded by clone C4 revealed several interesting features. Charged regions were found, which have been noted to be characteristic of autoantigens (26) . Two were acidic regions, one of which was particularly rich in glutamic acid (aa 310-330) (Fig. 5 A) . Similar acidic domains in GAL4 were felt to be important in transcriptional activation (27, 28) . Two were basic regions, which would be expected to have a high affinity for nucleic acids (29) . There were two proline-rich regions, which have been seen in proteins that bind single stranded nucleic acid, including proteins of Sm autoantigen (30, 31) . Three regions of relative abundance of proline (P), glutamic acid (E), serine (S), threonine (T), and aspartic acid (D) (PEST or PEST/D regions) were noted (32) (Fig. 5 A) . Such regions have been associated with proteins that undergo rapid intracellular degradation.
The encoded protein had four potential zinc finger motifs, although it is not known if these regions bind zinc or nucleic acids in this protein (33) (34) (35) . The histidine-cystine pattern differs from that of TFIIIA Zn fingers and other recognized families. The EST-encoded homologous protein was of particular interest, since it was a different protein fragment with an almost identical Zn-finger region, that included two Zn-fingers and an NH2 -terminal extension (Fig. 5 B) . A 32 aa region of the EST was identical to Mi-2, and includes its entire NH2-terminal Zn finger, plus the region between Zn fingers. The COOH-terminal Zn finger of the EST had the same form as that of Mi-2, with nearly complete identity in the putative Zn-binding regions and the same size loop. The limited reported sequence prevents more extensive analysis to determine its overall relatedness to Mi-2. The structure of the two sequential Zn fingers seen in Mi-2 and EST03869, as defined by the putative Zn-binding amino acids (C-X-X-C...C-X-X-C...H-X-X-C...C-X-X-C), was found in 14 other proteins, including the human proteins hrx, laminin a, laminin bl, and erb b-2 receptor, as well as the rat laminin b3 and neu, a papillomavirus protein, and others. The possible relationship of these proteins remains to be determined.
The presence of Zn fingers, proline-rich regions and charged regions suggests nucleic acid binding, raising the possibility of a role in DNA processing, regulation of transcription, or similar cellular processes, consistent with its nuclear localization. No nucleic acid has been found in association with Mi-2 antigen (9, 13), but this does not exclude nucleic acid binding. The fact that this protein is widely expressed and evolutionarily conserved (9) suggests that it is important in cellular function, but its role remains unknown, and the cDNA described here may help in determining its function.
